West Newton, MA, United States of America

Rajesh R Iyengar

This inventor holds 26 USPTO granted patents and 31 published patent applications, plus 4 CIPO patents and 14 EPO patents, primarily in sGC Stimulators. Top assignees: Cyclerion Therapeutics, Inc., Ironwood Pharmaceuticals, Inc., Abbott Laboratories Corporation. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajesh R Iyengar. Retrieved from https://idiyas.com/inventor/rajesh-r-iyengar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 69.2

 

 

Average Co-Inventor Count = 8.7

ph-index = 7

Forward Citations = 111(Granted Patents)


Location History:

  • Lindenhurst, IL (US) (2005 - 2006)
  • Newton, MA (US) (2012 - 2014)
  • West Newton, MA (US) (2012 - 2023)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
sGC Stimulators
CNS Diseases
Phosphorus Prodrugs
Pyrazolo-Substituted Pyrimidine
Diacylglycerol O-Acyltransferase
Thienopyridones
AMPK Activators
Anti-Bacterial Activity
Melanin Concentrating Hormone
Enzyme Inhibitors
26 patents (USPTO):Explore Patents

Title: Innovations by Rajesh R Iyengar: Pioneering CNS Treatments

Introduction

Rajesh R Iyengar, based in West Newton, MA, is a notable inventor with a remarkable portfolio of 25 patents. His contributions to the field of pharmaceutical science, particularly in the area of central nervous system (CNS) diseases, have paved the way for novel treatments and therapeutic strategies.

Latest Patents

Rajesh's latest innovations include the development of stimulators of soluble guanylate cyclase (sGC). These patents encompass pharmaceutical formulations aimed at treating various diseases by enhancing the concentration of nitric oxide (NO) and cyclic guanosine monophosphate (cGMP). The applications derived from his work target the upregulation of the NO pathway for treating CNS diseases, showcasing the dual focus on improving the efficacy of existing treatments and exploring new therapeutic avenues.

Career Highlights

Throughout his career, Rajesh has been associated with leading biotechnology companies, notably Cyclerion Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc. His innovative work in these organizations has contributed significantly to advancements in therapeutic solutions for complex medical conditions.

Collaborations

In his journey, Rajesh has collaborated with esteemed professionals in the field, including Thomas Wai-Ho Lee and Takashi Nakai. These partnerships have fostered a collaborative environment that enhances the creativity and impact of innovative solutions.

Conclusion

Rajesh R Iyengar stands out as an influential inventor whose dedication to advancing pharmacological treatments is evident through his extensive patent portfolio and collaborative efforts. His work continues to inspire developments in the treatment of CNS diseases, highlighting the essential role of innovation in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…